Zobrazeno 1 - 10
of 426
pro vyhledávání: '"M Unterrainer"'
Autor:
Ida Sonni, Andrei Gafita, Lena M. Unterrainer, Rejah M. Alano, Stephanie Lira, John Shen, Alexandra Drakaki, Tristan Grogan, Matthew B. Rettig, Johannes Czernin, Jeremie Calais
Publikováno v:
EJNMMI Research, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Background PSMA expression is influenced by hormonal status. We evaluated changes in PSA and whole-body 68Ga-PSMA-11 PET/CT (WB-PSMA PET) after initiation of androgen receptor signaling inhibitors (ARSi). Methods Prospectively enrolled patie
Externí odkaz:
https://doaj.org/article/fc9be906f81d4f2fb2a2b86d91fd4eaf
Autor:
Alexander Tamalunas, Can Aydogdu, Lena M. Unterrainer, Melanie Schott, Severin Rodler, Stephan Ledderose, Gerald B. Schulz, Christian G. Stief, Jozefina Casuscelli
Publikováno v:
Cancers, Vol 16, Iss 8, p 1536 (2024)
Background: Our study endeavors to elucidate the clinical implications of PD-L1 positivity in individuals afflicted with advanced urothelial carcinoma of the bladder (UCB). Methods: Patients with advanced UCB were prospectively enrolled following a r
Externí odkaz:
https://doaj.org/article/525a9133d1c44054a6f7ca54bb66cb72
Autor:
Sandra Resch, Sarah Takayama Fouladgar, Mathias Zacherl, Gabriel T. Sheikh, Grigory Liubchenko, Mikhail Rumiantcev, Lena M. Unterrainer, Vera Wenter, Peter Bartenstein, Sibylle I. Ziegler, Harun Ilhan, Leonie Beyer, Guido Böning, Astrid Delker
Publikováno v:
EJNMMI Physics, Vol 10, Iss 1, Pp 1-16 (2023)
Abstract Background 177Lu-PSMA therapy has been successfully used to prolong the survival of patients with metastatic castration-resistant prostate cancer. Patient-specific dosimetry based on serial quantitative SPECT/CT imaging can support the under
Externí odkaz:
https://doaj.org/article/2ce067d4e88d47b7b2920f87feaee6ca
Autor:
Lukas Gold, Enio Barci, Matthias Brendel, Michael Orth, Jiying Cheng, Sabrina V. Kirchleitner, Laura M. Bartos, Dennis Pötter, Maximilian A. Kirchner, Lena M. Unterrainer, Lena Kaiser, Sibylle Ziegler, Lorraine Weidner, Markus J. Riemenschneider, Marcus Unterrainer, Claus Belka, Joerg-Christian Tonn, Peter Bartenstein, Maximilian Niyazi, Louisa von Baumgarten, Roland E. Kälin, Rainer Glass, Kirsten Lauber, Nathalie L. Albert, Adrien Holzgreve
Publikováno v:
Biomedicines, Vol 12, Iss 1, p 188 (2024)
Background: The translocator protein (TSPO) has been proven to have great potential as a target for the positron emission tomography (PET) imaging of glioblastoma. However, there is an ongoing debate about the potential various sources of the TSPO PE
Externí odkaz:
https://doaj.org/article/bab7c24b04b64509ad8004cad24a8c44
Autor:
Vinh Ngoc Bui, Lena M. Unterrainer, Matthias Brendel, Sophie C. Kunte, Adrien Holzgreve, Fabian Allmendinger, Peter Bartenstein, Frederick Klauschen, Marcus Unterrainer, Michael Staehler, Stephan Ledderose
Publikováno v:
Biomedicines, Vol 11, Iss 11, p 3095 (2023)
In renal cell carcinoma (RCC), accurate imaging methods are required for treatment planning and response assessment to therapy. In addition, there is an urgent need for new therapeutic options, especially in metastatic RCC. One way to combine diagnos
Externí odkaz:
https://doaj.org/article/84e096e7d1ae45318b188c585e1092ea
Autor:
Ralf S. Eschbach, Markus Hofmann, Lukas Späth, Gabriel T. Sheikh, Astrid Delker, Simon Lindner, Klaus Jurkschat, Carmen Wängler, Björn Wängler, Ralf Schirrmacher, Reinhold Tiling, Matthias Brendel, Vera Wenter, Franziska J. Dekorsy, Mathias J. Zacherl, Andrei Todica, Harun Ilhan, Freba Grawe, Clemens C. Cyran, Marcus Unterrainer, Johannes Rübenthaler, Thomas Knösel, Tanja Paul, Stefan Boeck, Christoph Benedikt Westphalen, Christine Spitzweg, Christoph J. Auernhammer, Peter Bartenstein, Lena M. Unterrainer, Leonie Beyer
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
PurposeSomatostatin analogues (SSA) are frequently used in the treatment of neuroendocrine tumours. Recently, [18F]SiTATE entered the field of somatostatin receptor (SSR) positron emission tomography (PET)/computed tomography (CT) imaging. The purpos
Externí odkaz:
https://doaj.org/article/3d44f66487cd4f03ae7b9ac67d9471d4
Autor:
Adrien Holzgreve, Hans Roland Dürr, Axel Stäbler, Mathias Kaemmerer, Lena M. Unterrainer, Amanda Tufman, Farkhad Manapov, Wolfgang G. Kunz, Marcus Unterrainer
Publikováno v:
Diagnostics, Vol 13, Iss 5, p 901 (2023)
A 54-year-old patient presented with progressive pain for one month in the second finger of the right hand with an emphasis on the proximal interphalangeal (PIP) joint. Subsequent magnetic resonance imaging (MRI) showed a diffuse intraosseous lesion
Externí odkaz:
https://doaj.org/article/a3e3cfb33209446d827b54dad5a04df9
Autor:
M. Unterrainer, C. Eze, H. Ilhan, S. Marschner, O. Roengvoraphoj, N. S. Schmidt-Hegemann, F. Walter, W. G. Kunz, P. Munck af Rosenschöld, R. Jeraj, N. L. Albert, A. L. Grosu, M. Niyazi, P. Bartenstein, C. Belka
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-15 (2020)
Abstract Radiotherapy and radiation oncology play a key role in the clinical management of patients suffering from oncological diseases. In clinical routine, anatomic imaging such as contrast-enhanced CT and MRI are widely available and are usually u
Externí odkaz:
https://doaj.org/article/484dad0a5e324fbeb664b7c0b3ac5db3
Autor:
Katharina von Rohr, Marcus Unterrainer, Adrien Holzgreve, Maximilian A. Kirchner, Zhicong Li, Lena M. Unterrainer, Bogdana Suchorska, Matthias Brendel, Joerg-Christian Tonn, Peter Bartenstein, Sibylle Ziegler, Nathalie L. Albert, Lena Kaiser
Publikováno v:
Cancers, Vol 14, Iss 19, p 4860 (2022)
The purpose of this study was to evaluate the possibility of extracting relevant information from radiomic features even in apparently [18F]FET-negative gliomas. A total of 46 patients with a newly diagnosed, histologically verified glioma that was v
Externí odkaz:
https://doaj.org/article/8e0269bba99f470d844bd1da12ce2d85
Autor:
S. Rudisile, A. Gosewisch, V. Wenter, M. Unterrainer, G. Böning, F. J. Gildehaus, W. P. Fendler, C. J. Auernhammer, C. Spitzweg, P. Bartenstein, A. Todica, H. Ilhan
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background NETTER-1 trial demonstrated high efficacy and low toxicity of four cycles of Peptide Receptor Radionuclide Therapy (PRRT) in patients with metastasized NET. The present study evaluates the outcome of further PRRT cycles in the so
Externí odkaz:
https://doaj.org/article/b0ced27a889e4a45929580f8b04163d6